Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,554 | 289 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,038 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $734.32 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $525.82 | 35 | $0 (2024) |
| Lilly USA, LLC | $448.69 | 23 | $0 (2024) |
| PFIZER INC. | $290.33 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $220.32 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $146.15 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $115.62 | 9 | $0 (2020) |
| ABBVIE INC. | $109.80 | 6 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $108.71 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $641.46 | 34 | AstraZeneca Pharmaceuticals LP ($141.18) |
| 2023 | $625.69 | 35 | Lilly USA, LLC ($170.30) |
| 2022 | $356.81 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($142.60) |
| 2021 | $498.97 | 29 | Novo Nordisk Inc ($174.98) |
| 2020 | $728.18 | 46 | Boehringer Ingelheim Pharmaceuticals, Inc. ($146.44) |
| 2019 | $587.18 | 45 | Novo Nordisk Inc ($243.64) |
| 2018 | $481.71 | 37 | Novo Nordisk Inc ($145.96) |
| 2017 | $633.64 | 43 | AstraZeneca Pharmaceuticals LP ($151.92) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VACCINE | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 07/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 05/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.32 | General |
| 05/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Oncology | ||||||
| 04/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: PAIN | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 231 | 279 | $47,965 | $20,204 |
| 2022 | 5 | 182 | 218 | $39,645 | $17,908 |
| 2021 | 5 | 191 | 236 | $41,865 | $18,469 |
| 2020 | 6 | 243 | 288 | $38,885 | $16,307 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 87 | $18,270 | $7,146 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $10,810 | $6,135 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 82 | $14,350 | $4,428 | 30.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 23 | $2,220 | $1,536 | 69.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 25 | $875.00 | $801.25 | 91.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $1,440 | $157.17 | 10.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $11,515 | $6,686 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 68 | $14,305 | $5,967 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 65 | $11,375 | $3,461 | 30.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 18 | 18 | $1,800 | $1,234 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $650.00 | $559.26 | 86.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $11,200 | $6,869 | 61.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 94 | $19,750 | $6,550 | 33.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 59 | $8,620 | $3,639 | 42.2% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 16 | 17 | $1,700 | $1,105 | 65.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 17 | $595.00 | $305.43 | 51.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 93 | $16,800 | $5,605 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $9,240 | $5,156 | 55.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 73 | $8,395 | $2,681 | 31.9% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 34 | $2,840 | $2,049 | 72.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 34 | 34 | $1,190 | $603.14 | 50.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $420.00 | $212.64 | 50.6% |
About Dr. Eyad Homedi, M.D
Dr. Eyad Homedi, M.D is a Family Medicine healthcare provider based in Villa Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427034073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eyad Homedi, M.D has received a total of $4,554 in payments from pharmaceutical and medical device companies, with $641.46 received in 2024. These payments were reported across 289 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,554).
As a Medicare-enrolled provider, Homedi has provided services to 847 Medicare beneficiaries, totaling 1,021 services with total Medicare billing of $72,887. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Villa Park, IL
- Active Since 12/15/2005
- Last Updated 12/20/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1427034073
Products in Payments
- Ozempic (Drug) $628.88
- TRADJENTA (Drug) $296.02
- TRULICITY (Drug) $242.32
- FARXIGA (Drug) $222.32
- JARDIANCE (Drug) $221.62
- STIOLTO RESPIMAT (Drug) $160.50
- SYMBICORT (Drug) $153.16
- Victoza (Drug) $146.98
- JANUVIA (Drug) $128.60
- MOUNJARO (Drug) $124.91
- XARELTO (Drug) $107.29
- TRELEGY ELLIPTA (Drug) $102.66
- Rybelsus (Drug) $97.37
- Doc Band (Device) $93.23
- Myrbetriq (Drug) $91.62
- ADHANSIA XR (Drug) $83.14
- Cologuard Collection Kit (Device) $75.97
- PREVNAR 13 (Biological) $75.17
- PAXLOVID (Drug) $73.65
- BEVESPI AEROSPHERE (Drug) $72.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Villa Park
Dr. Anthony Lin, Md, MD
Family Medicine — Payments: $14,926
Dr. Linda Warner, D.o, D.O
Family Medicine — Payments: $1,858
Mrs. Kathleen Gallaher, M.d, M.D
Family Medicine — Payments: $1,546
Dr. Mohammed Samiruddin, M.d, M.D
Family Medicine — Payments: $1,472
Dr. Soha Sattar, M.d, M.D
Family Medicine — Payments: $156.73
Richard Novak, M.d, M.D
Family Medicine — Payments: $55.10